Approval · Notice of Compliance 244 · 2002
CATHFLO: Notice of Compliance 244
Issued May 10, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 244
- Date
- May 10, 2002
- Company
- Hoffmann-La Roche LimitedMississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority
- Therapeutic class
- Fibrinolytic agent (tissue plasminogen activator)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CATHFLO | 02245859 | Marketed |
Medicinal ingredients
- ALTEPLASE 1 MG per ML